Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Prif Awdur: | Siddika, Khadiza |
---|---|
Awduron Eraill: | Ahmed, Syeda Maliha |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2024
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/24296 |
Eitemau Tebyg
-
Targeted therapeutic options in the treatment of Breast Cancer
gan: Alam, Kazi Tasnuva
Cyhoeddwyd: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
gan: Rattry, Faria Rahman
Cyhoeddwyd: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
gan: Tania, Umme
Cyhoeddwyd: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
gan: Jahan, Nusrat
Cyhoeddwyd: (2024) -
Molecular biology : genes to proteins /
gan: Tropp, Burton E.
Cyhoeddwyd: (2008)